SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists
DRTS

Alpha Tau Medical Ltd. (NASDAQ:DRTS)

IL · Delayed Price · Currency is USD
Healthcare · Biotechnology
$11.76+$0.45 (+3.93%)
 
Market cap
$1.09B
Insider Score
Health Score
Analyst consensus
Listed since
Mar 8, 2021
Market Cap$1.09B+222.1%
Revenue (ttm)$0
Net Income-$111.04M-177.8%
EPS-$1.22-130.2%
Shares Out92.48M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume628,875
Open$11.52
Previous Close$11.31
Day's Range$11.39 - $12.04
52-Week Range$3.65 - $15.79
Beta1.29
AnalystsBuy
Price Target$23.00(+95.66%)
Earnings DateMar 8, 2027

About DRTS

Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer. Its Alpha-DaRT technology is in clinical trials for various forms comprising skin, oral, pancreatic, prostate, lung, liver, and breast cancers; and preclinical clinical studies for mouse tumors and human-derived tumors. The company is headquartered in Jerusalem, Israel.

Address
Kiryat HaMada St. 5, Jerusalem, JM, 9777605, IL
Market Cap
1.09 billion
Employees
121
Industrial Classification
Biotechnology

What Are Insiders Doing?

Open-market buy / sell balanceNet Selling
Sold
$1.56M
Bought
$0

View the trades behind this meter — each links to its SEC Form 4 →

Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.

Analyst consensus

Moderate Buy
3 Buy0 Hold0 SellAvg target $21.00 (+78.7%)

3 firms rating DRTS in the last 3 months, one vote each. Issuer-paid research is not counted.

Financial Health Score
Fair
From DRTS’s reported statements · Q3 2026 (trailing 12 months) · 4 of 5 pillars

Next catalysts

1 Day
+3.93%
5 Days
-17.22%
1 Month
-8.88%
6 Months
+17.08%
1 Year
+222.05%

$DRTS stock is featured in our Insider Trades datasets.

→ All Stock Lists

Recently reported changes in DRTS holdings by institutional investors

Scanning latest 13F filings…

Latest 0 13F filings · Source: SEC EDGAR

View all institutional owners →

Insider Trading

Quarterly net insider trading by DRTS's directors and management

Net Shares Purchased by Insiders−90k−45k02025Q42026Q12026Q22026Q32026Q4

Source: SEC EDGAR (Form 4)

Corporate Lobbying

DRTS Estimated quarterly lobbying spending

Source: U.S. Senate LDA

U.S. Patents

New DRTS patent grants

Loading patent grants…

Source: USPTO Open Data Portal

Government Contracts

Estimated quarterly amount awarded to DRTS from public contracts

Source: USAspending.gov

Top ETF Holders

ETFs with the largest estimated holdings in DRTS

IEFAiShares Core MSCI EAFE ETF$5.56M
SCZiShares MSCI EAFE Small-Cap ETF$2.62M
EISiShares MSCI Israel ETF$1.56M
IZRLARK Israel Innovative Technology ETF$1.53M
IXUSiShares Core MSCI Total International Stock ETF$744.43K
GWXState Street SPDR S&P International Small Cap ETF$440.34K

Estimated from each fund’s disclosed top holdings × AUM

Bull Case vs Bear Case

AI-generated from DRTS’s recent data — informational, not investment advice

Generating analysis…

What’s Behind the Score

Insider Activity
48% of score
0
Analyst Ratings
32% of score
99
News & Sentiment
20% of score
78

News check: Positive interim trial results with 100% ORR, analyst upgrade from Piper Sandler to Overweight, and successful trial endpoints justify bullish sentiment.

Recent Insider Activity

Buys
0
Sells
12
Buy Value
$0
Distinct Buyers
0

Frequently Asked Questions

Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.

ETFs that hold this stock

IZRLARK Israel Innovative Technology ETF1.52%
EHLSEven Herd Long Short ETF0.62%
EISiShares MSCI Israel ETF0.21%

Weight is the stock’s share of each fund’s holdings.